The main aim of this study is to determine whether an intervention through an exercise-based CR program could effectively prevent cardiotoxicity induced by anthracyclines and/or anti-HER2 antibodies in women with breast cancer at early stages, as compared with usual care and physical activity recommendation. The gene discussed is ERBB2; the disease is breast cancer.